iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 42nd Annual J.P. Morgan Healthcare Conference.
Related news for (IRTC)
- iRhythm Technologies Announces First Quarter 2025 Financial Results
- iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results
- iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference
- irhythm technologies announces third quarter 2024 financial results
- irhythm technologies enters license agreement with biointellisense for multiparameter sensor technology to be used in ambulatory cardiac monitoring